• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Eli Lilly - Articles and news items

Eli Lilly to aquire pain biotech CoLucid for $960 million

Industry news / 19 January 2017 / Niamh Marriott, Digital Editor

This transaction will be acting to enhance Lilly’s existing portfolio in pain management for migraine, while adding a potential near-term launch…

FDA extends review period for Eli Lilly’s rheumatoid arthritis drug

Industry news / 16 January 2017 / Niamh Marriott, Digital Editor

Baricitinib is also being studied in phase 2 trials for atopic dermatitis and systemic lupus erythematosus, and a phase 3 trial for patients…

cardiovascular death

FDA approves drug that reduces risk of cardiovascular death in diabetics

Industry news / 12 December 2016 / Niamh Louise Marriott, Digital Editor

It significantly reduced the risk of (the combined primary endpoint) cardiovascular death, non-fatal heart attack or non-fatal stroke by 14% versus placebo…

EC approval for Lilly’s soft tissue sarcoma drug Olaratumab

Industry news / 18 November 2016 / Niamh Louise Marriott, Digital Content Producer

This conditional marketing authorisation is based on data from the Phase 2 portion of the pivotal JGDG trial and followed a positive recommendation from…

Re-evaluating the Cancer Drugs Fund: Out with the old, in with the new

Blog, Z Homepage promo / 31 August 2016 / Niamh Louise Marriott, Digital Content Producer

In April of this year, NICE started to assess the cost and clinical effectiveness of every drug currently in the old cancer drugs fund…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +